(Q69905224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Clinical significance of anti-IFN-alpha antibody titres during interferon therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

P von Wussow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

M Freund

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

B Block

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H Diedrich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H Poliwoda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

H Deicher

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

language of work or name

English

0 references

publication date

1 September 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

8559

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

635-636

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

Interferon-neutralizing antibodies in a patient treated with human fibroblast interferon

6 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Treatment of hairy-cell leukaemia with recombinant human alpha 2-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Low incidence of serum neutralizing factors in patients receiving recombinant alfa-2b interferon (Intron A)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Patient with circulating antibodies to alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Incidence and clinical significance of neutralizing antibodies in patients receiving recombinant interferon alfa-2a by intramuscular injection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

A radioimmunologic technique to screen for antibodies to α-2 interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

Antibodies to human leucocyte interferons in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2887%2993034-0

7 January 2021

10.1016/S0140-6736(87)93034-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2887929%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

1 reference